CClinicalTrials.gg
CompletedNCT05528016Updated Sep 6, 2022

Short and Long-term Results of Skin Versus Skin Plus Orbicularis Resection Blepharoplasty

An interventional study of Upper Eyelid Blepharoplasty in Dermatochalasis of Eyelid, Ocular Surface Disease and Meibomian Gland Dysfunction, sponsored by Marmara University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-09-06.

Sponsored by Marmara University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled May 2021, registered Aug 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study aims to evaluate the short and long-term effects of skin-only and skin+muscle excision blepharoplasty on corneal nerves, dry eye parameters, meibomian glands, and eyebrow position.

Read the detailed description

The study was designed with the approval of the Ethics Committee on Human Research of Marmara University and was conducted following the tenets of the Declaration of Helsinki. Written informed consent was obtained from all patients who received information about the procedure and the postoperative course. The study included 48 eyes of 24 patients older than 18 who applied to Marmara University Oculoplastic and Orbital Surgery Unit due to dermatochalasis and were suggested upper eyelid blepharoplasty for medical or cosmetic purposes. The patients were divided into two groups, Group S (n=12) for skin excision only and Group M (n=12) for skin+muscle excision by the decision of the surgeon. In addition to all ophthalmological examinations, sub-basal nerve plexus parameters with corneal confocal microscopy, Schirmer I test, non-invasive tear break-up time, meibomian gland area loss measurements with infrared meibography, central eyebrow height, and lateral eyebrow height were evaluated at baseline and postoperative 1st week, 1st month and 1st-year follow-ups.

02

Conditions studied

  • Dermatochalasis of Eyelid
  • Ocular Surface Disease
  • Meibomian Gland Dysfunction
  • Dry Eye
  • Brow Ptosis

Keywords

  • blepharoplasty
  • skin
  • orbicularis oculi
  • corneal confocal microscopy
  • meibomian gland
  • dry eye
  • eyebrow
03

In context

Dry Eye Syndromes

1,292 studies on the registry are indexed under Dry Eye Syndromes; 191 are open to participants now.

This study's enrollment of 24 is below the median of 60 across 1,077 interventional studies indexed under Dry Eye Syndromes.

Browse Dry Eye Syndromes studies →

Lead sponsor

Marmara University is the lead sponsor of 576 studies on the registry; 136 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients older than 18.
  • Patients with dermatochalasis.
  • Patients who were suggested upper eyelid blepharoplasty for medical or cosmetic purposes.

Exclusion criteria

Exclusion Criteria:

  • Patients who have had previous periorbital or ophthalmic surgery
  • Patients with extensive blepharitis
  • History of contact lens use
  • History of ophthalmic, endocrinological, neurological, or rheumatological diseases
  • History of facial paralysis
  • Negative Bell's phenomenon
  • Schirmer test \<5mm
  • The patients who had been treated with periocular botulinum toxin in the last 1 year were not included the study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
24 participants (actual)

Study arms

  • Active comparator
    Skin-Only Blepharoplasty

    Only the skin excision was performed for upper eyelid dermatochalasis.

    Procedure: Upper Eyelid Blepharoplasty

  • Active comparator
    Skin+Muscle Blepharoplasty

    Skin plus muscle excision was performed for upper eyelid dermatochalasis.

    Procedure: Upper Eyelid Blepharoplasty

Interventions

  • ProcedureUpper Eyelid Blepharoplasty

    Blepharoplasty is a procedure that the skin, orbicularis oculi muscle, and fat pads are excised to treat visual field loss caused by dermatochalasis.

06

What researchers measure

Primary outcomes

  1. Corneal nerve fiber density (CNFD)

    Automated tracing of nerve fibers program - CCMetrics (CCMetrics; University of Manchester, Manchester, UK) was used to analyze CNFD in fibers/mm2

    Time frame: Baseline / 1 Week / 1 Month / 1 Year

  2. Corneal nerve branch density (CNBD)

    Automated tracing of nerve fibers program - CCMetrics (CCMetrics; University of Manchester, Manchester, UK) was used to analyze CNBD in branches/mm2.

    Time frame: Baseline / 1 Week / 1 Month / 1 Year

  3. Corneal nerve fiber length (CNFL)

    Automated tracing of nerve fibers program - CCMetrics (CCMetrics; University of Manchester, Manchester, UK) was used to analyze CNBD in mm/mm2.

    Time frame: Baseline / 1 Week / 1 Month / 1 Year

  4. Eyebrow position

    Millimetric measurement was performed to evaluate the effect of blepharoplasty on eyebrow position.

    Time frame: Baseline / 1 Week / 1 Month / 1 Year

  5. Meibomian Gland Area Loss (MGAL)

    Phoenix-Meibography Imaging software that is available in the Sirius® Scheimpflug topographer (Sirius, CSO, Italy) was used to evaluate meibomian gland area loss in percentage.

    Time frame: Baseline / 1 Week / 1 Month / 1 Year

  6. Non-invasive Tear Break-Up Time (NI-BUT)

    Phoenix-Meibography Imaging software that is available in the Sirius® Scheimpflug topographer (Sirius, CSO, Italy) was used to evaluate non-invasive tear break-up time in seconds.

    Time frame: Baseline / 1 Week / 1 Month / 1 Year

07

Study locations

1 site
  • Marmara University Pendik Research and Educational Hospital
    Istanbul, Pendik 34899, Turkey
08

References and documents

Individual participant data

Plan to share: No — The data supporting the study findings are available from the corresponding author upon request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05528016
Lead sponsor
Marmara University
Responsible party
Sponsor
First posted
Sep 6, 2022
Start date
May 1, 2021
Primary completion
Jul 1, 2022
Completion
Aug 1, 2022
Last update
Sep 6, 2022

Study contacts

Volkan Dericioğlu, M.D
principal investigator · Marmara University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion